Interestingly, there is a correlation between exercise routines and the amelioration of symptoms in AD [112,113]; this information suggests that Gpld1 and CLU should be considered to treat AD since they could be administered intravenously and freely reach the affected areas of the brain. This evidence concerns the gene GPLD1 and Alzheimer disease.